FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 307 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Revumenib for Relapsed or Refractory Acute Myeloid Leukaemia with a Susceptible NPM1 Mutation Antitumour Activity of Patritumab Deruxtecan in Heavily Pretreated Patients with Active Brain Metastases of Breast Cancer and NSCLC EMA Recommends Extension of Indications for Sugemalimab MOST POPULAR Grandparents of children with cancer: “I would never want to go... September 1, 2020 Keeping progress in oncology on the agenda: ESMO honours recipients of... December 3, 2020 Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients... April 7, 2025 Helping Dogs—and Humans—with Cancer: NCI’s Comparative Oncology Studies July 10, 2019 Load more HOT NEWS CEDM Reveals A Clearer Image Of Potential Breast Cancer And Reduces... NICE doesn’t recommend olaparib for patients with certain prostate cancers How Can I Get the Latest Cancer Drug? Age: the forgotten cancer risk factor?
